These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 28649984)

  • 1. CD27 expression and its association with clinical outcome in children and adults with pro-B acute lymphoblastic leukemia.
    Chen D; Gerasimčik N; Camponeschi A; Tan Y; Wu Q; Brynjolfsson S; Zheng J; Abrahamsson J; Nordlund J; Lönnerholm G; Fogelstrand L; Mårtensson IL
    Blood Cancer J; 2017 Jun; 7(6):e575. PubMed ID: 28649984
    [No Abstract]   [Full Text] [Related]  

  • 2. CD44 and CD27 expression pattern in B cell precursor acute lymphoblastic leukemia and its clinical significance.
    Kamazani FM; Bahoush GR; Aghaeipour M; Vaeli S; Amirghofran Z
    Med Oncol; 2013 Mar; 30(1):359. PubMed ID: 23263849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD99 expression is strongly associated with clinical outcome in children with B-cell precursor acute lymphoblastic leukaemia.
    Chen D; Camponeschi A; Wu Q; Gerasimcik N; Li H; Shen X; Tan Y; Sjögren H; Nordlund J; Lönnerholm G; Abrahamsson J; Fogelstrand L; Mårtensson IL
    Br J Haematol; 2019 Feb; 184(3):418-423. PubMed ID: 30484860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression of CD40 on B-cell precursor acute lymphoblastic leukemia blasts is an independent risk factor associated with improved survival and enhanced capacity to up-regulate the death receptor CD95.
    Troeger A; Glouchkova L; Ackermann B; Escherich G; Meisel R; Hanenberg H; den Boer ML; Pieters R; Janka-Schaub GE; Goebel U; Laws HJ; Dilloo D
    Blood; 2008 Aug; 112(4):1028-34. PubMed ID: 18552209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of CD200 and CD56 expression in pediatric B-cell acute lymphoblastic leukemia patients.
    Aref S; Azmy E; El-Bakry K; Ibrahim L; Abdel Aziz S
    Pediatr Hematol Oncol; 2017 Aug; 34(5):275-285. PubMed ID: 29144828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD123 expression patterns and selective targeting with a CD123-targeted antibody-drug conjugate (IMGN632) in acute lymphoblastic leukemia.
    Angelova E; Audette C; Kovtun Y; Daver N; Wang SA; Pierce S; Konoplev SN; Khogeer H; Jorgensen JL; Konopleva M; Zweidler-McKay PA; Medeiros LJ; Kantarjian HM; Jabbour EJ; Khoury JD
    Haematologica; 2019 Apr; 104(4):749-755. PubMed ID: 30361418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survivin and its prognostic significance in pediatric acute B-cell precursor lymphoblastic leukemia.
    Troeger A; Siepermann M; Escherich G; Meisel R; Willers R; Gudowius S; Moritz T; Laws HJ; Hanenberg H; Goebel U; Janka-Schaub GE; Mahotka C; Dilloo D
    Haematologica; 2007 Aug; 92(8):1043-50. PubMed ID: 17640858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic and therapeutic role of targetable lesions in B-lineage acute lymphoblastic leukemia without recurrent fusion genes.
    Messina M; Chiaretti S; Wang J; Fedullo AL; Peragine N; Gianfelici V; Piciocchi A; Brugnoletti F; Di Giacomo F; Pauselli S; Holmes AB; Puzzolo MC; Ceglie G; Apicella V; Mancini M; Te Kronnie G; Testi AM; Vitale A; Vignetti M; Guarini A; Rabadan R; Foà R
    Oncotarget; 2016 Mar; 7(12):13886-901. PubMed ID: 26883104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokines and microRNA in pediatric B-acute lymphoblastic leukemia.
    Cocco C; Airoldi I
    Cytokine Growth Factor Rev; 2011 Jun; 22(3):149-56. PubMed ID: 21764355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Favorable outcome of NUTM1-rearranged infant and pediatric B cell precursor acute lymphoblastic leukemia in a collaborative international study.
    Boer JM; Valsecchi MG; Hormann FM; Antić Ž; Zaliova M; Schwab C; Cazzaniga G; Arfeuille C; Cavé H; Attarbaschi A; Strehl S; Escherich G; Imamura T; Ohki K; Grüber TA; Sutton R; Pastorczak A; Lammens T; Lambert F; Li CK; Carrillo de Santa Pau E; Hoffmann S; Möricke A; Harrison CJ; Den Boer ML; De Lorenzo P; Stam RW; Bergmann AK; Pieters R
    Leukemia; 2021 Oct; 35(10):2978-2982. PubMed ID: 34211097
    [No Abstract]   [Full Text] [Related]  

  • 11. Significantly increased CD70 up regulation on TEL-AML positive B cell precursor acute lymphoblastic leukemia cells following CD40 stimulation.
    Troeger A; Glouchkova L; Ackermann B; Escherich G; Hanenberg H; Janka G; Roettgers S; Göbel U; Dilloo D
    Klin Padiatr; 2014 Nov; 226(6-7):332-7. PubMed ID: 25062112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of VEGF and VEGF receptors in childhood precursor B-cell acute lymphoblastic leukemia evaluated by immunohistochemistry.
    Diffner E; Gauffin F; Anagnostaki L; Nordgren A; Gustafsson B; Sander B; Gustafsson B; Persson JL
    J Pediatr Hematol Oncol; 2009 Sep; 31(9):696-701. PubMed ID: 19707156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of sex in childhood B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group Study.
    Shuster JJ; Wacker P; Pullen J; Humbert J; Land VJ; Mahoney DH; Lauer S; Look AT; Borowitz MJ; Carroll AJ; Camitta B
    J Clin Oncol; 1998 Aug; 16(8):2854-63. PubMed ID: 9704739
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Hormann FM; Hoogkamer AQ; Beverloo HB; Boeree A; Dingjan I; Wattel MM; Stam RW; Escherich G; Pieters R; den Boer ML; Boer JM
    Haematologica; 2019 Oct; 104(10):e455-e459. PubMed ID: 30872366
    [No Abstract]   [Full Text] [Related]  

  • 15. Wntless (GPR177) expression correlates with poor prognosis in B-cell precursor acute lymphoblastic leukemia via Wnt signaling.
    Chiou SS; Wang LT; Huang SB; Chai CY; Wang SN; Liao YM; Lin PC; Liu KY; Hsu SH
    Carcinogenesis; 2014 Oct; 35(10):2357-64. PubMed ID: 25115440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precursor B- or T-lymphoblastic lymphoma presenting with cutaneous involvement: a series of 13 cases including 7 cases of cutaneous T-lymphoblastic lymphoma.
    Lee WJ; Moon HR; Won CH; Chang SE; Choi JH; Moon KC; Lee MW
    J Am Acad Dermatol; 2014 Feb; 70(2):318-25. PubMed ID: 24314877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relapsed B-acute lymphoblastic leukemia with aberrant myeloperoxidase expression following CAR T-cell therapy: A diagnostic challenge.
    Li N; Wang SA; Lin P; Jabbour E; Thompson P; Chen Z; Li S; Xu J; You MJ; Bueso-Ramos CE; Medeiros LJ; Yin CC
    Am J Hematol; 2019 Sep; 94(9):1049-1051. PubMed ID: 30916805
    [No Abstract]   [Full Text] [Related]  

  • 18. The BCL-2 protein in precursor B acute lymphoblastic leukemia in children.
    Chaber R; Fiszer-Maliszewska L; Noworolska-Sauren D; Kwasnicka J; Wrobel G; Chybicka A
    J Pediatr Hematol Oncol; 2013 Apr; 35(3):180-7. PubMed ID: 23511489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of Akt is associated with poor prognosis and chemotherapeutic resistance in pediatric B-precursor acute lymphoblastic leukemia.
    Morishita N; Tsukahara H; Chayama K; Ishida T; Washio K; Miyamura T; Yamashita N; Oda M; Morishima T
    Pediatr Blood Cancer; 2012 Jul; 59(1):83-9. PubMed ID: 22183914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Recurrent Refractory Pediatric Pre-B Acute Lymphoblastic Leukemia Using Inotuzumab Ozogamicin Monotherapy Resulting in CD22 Antigen Expression Loss as a Mechanism of Therapy Resistance.
    Paul MR; Wong V; Aristizabal P; Kuo DJ
    J Pediatr Hematol Oncol; 2019 Nov; 41(8):e546-e549. PubMed ID: 30807395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.